FeesSafety
Pluang+

Cre8 Enterprise completes $800K acquisition of LingXpert to boost translation capacity and efficiency.

Company Fundamentals
03 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Bullish
Cre8 Enterprise completes $800K acquisition of LingXpert to boost translation capacity and efficiency.

Cre8 Enterprise Limited, a Hong Kong-based financial printing service provider, has completed the acquisition of Lingxpert Language Services Limited for $800,000 in cash. This move aims to enhance Cre8's translation capabilities, reduce bottlenecks, and improve turnaround times for IPO and non-IPO projects. The acquisition also supports resource sharing to lower overhead costs and accelerate project delivery, helping Cre8 scale operations more effectively in the financial services sector.

Cre8 Enterprise Limited's acquisition news is presented with context from the Financials sector on Pluang. Of 142 priced Financials-sector US stocks tradable on Pluang, 56 rose and 77 fell today. Notable movers include AVAT at USD 0.88 with a 3.67% increase and a Pluang order activity of 29% Sell / 71% Buy, BTBT at USD 0.76 up 3.32% with 43% Sell / 57% Buy, and RJF at USD 157.25 down 3.11% with a typical hold time of 77 days. Data is as of Nov 03, 2026 18:42 WIB.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
21 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
3 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
3 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
3 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App